Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Legal Status of EPT in Oregon

permissibleEPT is permissible.

This is a table caption for compliance. Ignore it please.
I. Statutes/regs on health care providers’ authority to prescribe for STDs to a patient’s partner(s) w/out prior evaluation (Explanation) minus symbol Prescription drugs dispensed by a physician shall be personally dispensed by the physician. Or. Rev. Stat. § 677.089(1); see also Or. Admin R. 333-076-0145(4).

plus sign Amendments and new rules within the Board of Pharmacy will permit pharmacists, nurse practitioners, Clinical Nurse Specialists and other practitioners . . . to prescribe and dispense, within their scope of practice, specified drugs for an unnamed patient when the prescription is identified as “for EPT Therapy”. Or. Admin R. 855-041-4000 and 855-043-0003

plus sign Certain health professional regulatory boards can adopt rules that permit practitioners to prescribe or dispense antibiotic drugs to partners of patients without examining the partner for treatment of sexually transmitted diseases. Or. Rev. Stat. § 676.350

II. Specific judicial decisions concerning EPT (or like practices) (Explanation)
III. Specific administrative opinions by the Attorney General or medical or pharmacy boards concerning EPT (or like practices) (Explanation) plus sign The State Medical Board of Oregon recognizes that EPT is “often the only reasonable way to access and treat the partner(s) and impact the personal and public health risks of continued, or additional, chlamydial and gonorrheal infections. The Board urges practitioners to use all reasonable efforts to assure that appropriate information and advice are made available to the absent, treated third party or parties”
Adopted April 2007
IV. Laws that incorporate via reference guidelines as acceptable practices (including EPT) (Explanation)
V. Prescription requirements (Explanation) minus symbol Dispensing physicians shall label prescription drugs with the name of the patient. Or. Rev. Stat. § 677.089(3)(a).

plus sign “. . . the pharmacist or pharmacy intern shall state or cause to be stated on the label the following: (d) The name of the patient, unless the drug is prescribed to a partner of a patient as defined in Or. Rev. Stat. § 676.350 in accordance with rules adopted under Or. Rev. Stat. § 676.350 authorizing the practice of expedited partner therapy.” Or. Rev. Stat. § 689.505(5)

VI. Assessment of EPT’s legal status with brief comments (Explanation) permissibleEPT is permissible.

Statutory authority allows certain health professional boards to adopt rules that permit EPT.

Status as of January 1, 2010

Legend

plus sign supports the use of EPT

minus symbol negatively affects the use of EPT

permissible EPT is permissible

potentially allowable EPT is potentially allowable

prohibited EPT is prohibited

This is a table caption for compliance. Ignore it please.
permissible EPT is permissible in 42 states: potentially allowable EPT is potentially allowable in 6 states: prohibited EPT is prohibited in 2 states:
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Mexico
New York
North Carolina
North Dakota
Ohio
Oregon
Pennsylvania
Rhode Island
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
EPT is permissible in the District of Columbia.
Alabama
Delaware
Kansas
New Jersey
Oklahoma
South Dakota
EPT is potentially allowable in Puerto Rico.
Kentucky
South Carolina

  

Summary Totals

The information presented here is not legal advice, nor is it a comprehensive analysis of all the legal provisions that could implicate the legality of EPT in a given jurisdiction.  The data and assessment are intended to be used as a tool to assist state and local health departments as they determine locally appropriate ways to control STDs.

For comments, feedback and updates, please contact CDC-INFO: https://www.cdc.gov/cdc-info/.

TOP